sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Mon Jul 21
Sun Jul 20
Stock market today: Dow, S&P 500, Nasdaq futures wobble amid wave of earnings as tariffs bite GM profit
1mo
Y
Stock market today: Dow, S&P 500, Nasdaq futures trade flat as Wall Street braces for Big Tech earnings
1mo
Y
Stock market today: Dow, S&P 500, Nasdaq futures slip in wave of earnings as tariffs bite GM profit
1mo
Y
Stock market today: Dow, S&P 500, Nasdaq futures slip as Wall Street braces for the next wave of earnings
1mo
Y
This High-Yield Dividend Stock (8.3%) Has Analysts Saying ‘Strong Buy’ — Should You?
1mo
Y
Chip giant TSMC is the newest member of the $1 trillion market-cap club
1mo
Y
Why AT&T Stock Jumped Today
1mo
Y
‘Rich Dad Poor Dad’ author tells Americans to stop saving dollars
1mo
Y
Over 99% of XRP holders are in profit
1mo
Y
3iQ bets on regulated crypto access as institutional demand heats up
1mo
Y
Ready to retire in 5 years? Here’s your checklist
1mo
Y
Is A Bitcoin and Ethereum Treasury Company Bubble Forming?
1mo
Y
AstraZeneca Plans to Invest $50 Billion in U.S. by 2030
1mo
Y
Universal Music Group Files for Public Offering
1mo
Y
SoftBank and OpenAI’s $500 Billion AI Project Struggles to Get Off Ground
1mo
Y
Trader dumps asset after turning $100 into $2M
1mo
Y
Cotton Falls to Start the Week
1mo
Y
Corn Gives Back Gains as Crop Ratings Hold Steady
1mo
Y
The Stock Market’s Momentum Is Stalling With Mag 7 Earnings on Deck
1mo
Y
Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars
1mo
Y
Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal
1mo
Y
United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag
1mo
Y
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
1mo
Y
Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production
1mo
Y
AstraZeneca PLC (AZN)’s Datroway Wins FDA Nod for Lung Cancer Breakthrough
1mo
Y
Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia
1mo
Y
Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth
1mo
Y
Johnson & Johnson (JNJ)’s Pasritamig Shows Breakthrough Promise in Prostate Cancer
1mo
Y
Activist Elliott grows stake in Equinix, holds talks with company
1mo
Y
Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age
1mo
Y
Pump Up Your Portfolio With Petrobras
1mo
S
Podcast: Stocks Edge Higher as Earnings Season Ramps Up
1mo
Y
How to file a homeowners insurance claim
1mo
Y
Astera Labs Stocks and 2 More Recent IPOs That Look Strong Right Now
1mo
Y
Brazil planemaker Embraer ends Q2 with record $30 billion backlog
1mo
Y
AstraZeneca unveils $50 billion US investment as pharma tariff threat looms
1mo
Y
AstraZeneca announces $50 billion US manufacturing investment, matching its big pharma peers
1mo
Y
The surprising details of fashion entrepreneur Christine Hunsicker’s fraud indictment
1mo
Y
W.R. Berkley Profit Rises Despite Continued Surge in Catastrophe Losses
1mo
Y
Solana soars as DeFi amasses 999,999 SOL tokens on its balance sheet
1mo
Y
Why Archer Aviation Stock Plummeted Today
1mo
Y
The Dollar Pushes Lower. These ETFs Gain Most When It Falls.
1mo
Y
BYD Is One Of The Best Investments On The Market, Period
1mo
S
G-III Brings War of Words to PVH in Licensing Lawsuit
1mo
Y
Top analyst predicts new S&P 500 stock could soon double amid latest move
1mo
Y
Trading Day: Equity optimism hard to quell
1mo
Y
As Trump Bets Big on Rare Earth Magnets, This Hidden-Gem Stock Could Soar
1mo
Y
Stock Tokens Are Coming. Schwab, Interactive Brokers CEOs Don’t Like It.
1mo
Y
$356M in Assets Leaves DIA as Dow Falls on EU Tariff Demands
1mo
Y
Heard on the Street Recap: Atlantic Divide
1mo
Y
More →